Loading...
XHKG
1358
Market cap197mUSD
Jul 10, Last price  
1.08HKD
1D
0.00%
1Q
-4.42%
Jan 2017
-46.53%
IPO
-68.70%
Name

PW Medtech Group Ltd

Chart & Performance

D1W1MN
XHKG:1358 chart
P/E
14.19
P/S
1.63
EPS
0.07
Div Yield, %
8.98%
Shrs. gr., 5y
-0.76%
Rev. gr., 5y
27.20%
Revenues
824m
+7.10%
331,541,000457,083,000608,059,000515,587,000319,583,000286,913,000310,813,000362,183,000247,352,000271,399,000536,826,000675,084,000768,903,000823,505,000
Net income
94m
-37.41%
44,668,00077,905,000176,630,000208,582,000109,136,0004,519,000114,812,00081,982,000631,814,000739,120,000106,041,000153,184,000150,780,00094,374,000
CFO
241m
-24.41%
24,906,00052,807,00086,100,000259,975,000266,763,000183,777,00097,705,00099,993,00078,204,00037,243,000269,233,000211,031,000318,426,000240,704,000
Dividend
Jul 02, 20260.02 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Operating within the People's Republic of China, PW Medtech Group Limited is an investment holding company primarily engaged in the medical device industry. The company specializes in the manufacturing and distribution of a diverse portfolio of medical consumables, including various types of infusion sets such as non-PVC, precision filter, and light-resistant models, alongside intravenous cannula products and insulin needles and pens. Beyond its core medical device activities, the group also provides property management services. Established in 1997, the company, previously known as Pyholding Limited, maintains its corporate headquarters in Beijing, China.
IPO date
Nov 08, 2013
Employees
1,187
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT